European equities traded in the US as American depositary receipts were treading water late Thursday morning, nudging 0.1% lower to 1,424.33 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by internet browser company Opera (OPRA) and internet ad agency Criteo (CRTO), which rose 2.8% and 2%, respectively. They were followed by Sequans Communications S.A. (SQNS) and biopharmaceutical company Cellectis (CLLS), which were up 1.7% and 1.3%, respectively.
The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and biotech firm Evaxion Biotech (EVAX), which fell 6% and 3% respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company Grifols (GRFS), which were up 2.7% and 2.3%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and cruise line operator Carnival (CUK), which advanced 16% and 3.7%, respectively. They were followed by alcoholic beverage company Diageo (DEO) and biopharmaceutical company Bicycle Therapeutics (BCYC), which increased 2.6% each.
The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which fell 2.8% and 2%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company AstraZeneca (AZN), which were down 1.7% each.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。